These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 35901953

  • 21. Deleterious effect of anti-angiotensin II type 1 receptor antibodies detected pretransplant on kidney graft outcomes is both proper and synergistic with donor-specific anti-HLA antibodies.
    Malheiro J, Tafulo S, Dias L, Martins S, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    Nephrology (Carlton); 2019 Mar; 24(3):347-356. PubMed ID: 29451342
    [Abstract] [Full Text] [Related]

  • 22. Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies.
    Philogene MC, Bagnasco S, Kraus ES, Montgomery RA, Dragun D, Leffell MS, Zachary AA, Jackson AM.
    Transplantation; 2017 Mar; 101(3):608-615. PubMed ID: 27222934
    [Abstract] [Full Text] [Related]

  • 23. Angiotensin II type 1 receptor antibodies in kidney transplantation: An evidence-based comprehensive review.
    Sorohan BM, Ismail G, Leca N, Tacu D, Obrișcă B, Constantinescu I, Baston C, Sinescu I.
    Transplant Rev (Orlando); 2020 Oct; 34(4):100573. PubMed ID: 33002671
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of AT1R antibody (AT1R-Ab) among Malaysian multi-ethnic population.
    Jalalonmuhali M, Caroll R, Deayton S, Emery T, Humphreys I, Lim SJ, Lim SK, Coates T.
    Hum Immunol; 2020 Dec; 81(12):679-684. PubMed ID: 32736900
    [Abstract] [Full Text] [Related]

  • 25. Pre-transplant angiotensin II receptor type I antibodies in pediatric renal transplant recipients: An observational cohort study.
    Pizzo H, Mirocha J, Choi J, Garrison J, Haas M, Zhang X, Kamil ES, Kim I, Jordan SC, Puliyanda DP.
    Pediatr Transplant; 2022 Dec; 26(8):e14400. PubMed ID: 36168673
    [Abstract] [Full Text] [Related]

  • 26. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.
    Min JW, Lee H, Choi BS, Park CW, Yang CW, Kim YS, Choi YJ, Oh EJ, Chung BH.
    Ann Lab Med; 2018 Sep; 38(5):450-457. PubMed ID: 29797816
    [Abstract] [Full Text] [Related]

  • 27. The role of endothelin II type A receptor (ETAR) in transplant injury.
    Nowańska K, Wiśnicki K, Kuriata-Kordek M, Krajewska M, Banasik M.
    Transpl Immunol; 2022 Feb; 70():101505. PubMed ID: 34793957
    [Abstract] [Full Text] [Related]

  • 28. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Kamińska D, Bartoszek D, Zabińska M, Myszka M, Zmonarski S, Protasiewicz M, Nowakowska B, Hałoń A, Chudoba P, Klinger M.
    Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
    [Abstract] [Full Text] [Related]

  • 29. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Krajewska M, Mazanowska O, Kamińska D, Bartoszek D, Zabińska M, Myszka M, Nowakowska B, Hałoń A, Dawiskiba T, Chudoba P, Klinger M.
    Transpl Immunol; 2014 Jan; 30(1):24-9. PubMed ID: 24184747
    [Abstract] [Full Text] [Related]

  • 30. Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient.
    Guzzo I, Morolli F, Camassei FD, Piazza A, Poggi E, Dello Strologo L.
    Pediatr Nephrol; 2017 Jan; 32(1):185-188. PubMed ID: 27752765
    [Abstract] [Full Text] [Related]

  • 31. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
    Cuevas E, Arreola-Guerra JM, Hernández-Méndez EA, Salcedo I, Castelán N, Uribe-Uribe NO, Vilatobá M, Contreras-Saldívar AG, Sánchez-Cedillo AI, Ramírez JB, de Rungs D, Granados J, Morales-Buenrostro LE, Alberú J.
    Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
    [Abstract] [Full Text] [Related]

  • 32. Clinical conundrums in pediatric kidney transplantation: What we know about the role of angiotensin II type I receptor antibodies in pediatric kidney transplantation and the path forward.
    Pearl MH.
    Pediatr Transplant; 2024 May; 28(3):e14762. PubMed ID: 38650537
    [Abstract] [Full Text] [Related]

  • 33. Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome.
    Reinsmoen NL, Lai CH, Mirocha J, Cao K, Ong G, Naim M, Wang Q, Haas M, Rafiei M, Czer L, Patel J, Kobashigawa J.
    Transplantation; 2014 Mar 15; 97(5):595-601. PubMed ID: 24162250
    [Abstract] [Full Text] [Related]

  • 34. Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation.
    Lee J, Park Y, Kim BS, Lee JG, Kim HJ, Kim YS, Huh KH.
    Transplant Proc; 2015 Apr 15; 47(3):649-52. PubMed ID: 25891704
    [Abstract] [Full Text] [Related]

  • 35. Angiotensin II type 1 receptor antibodies and native kidney function in pediatric liver and intestinal transplant recipients.
    Stern R, Chen L, Chan AP, Wozniak LJ, Pearl M.
    Pediatr Nephrol; 2023 Dec 15; 38(12):4175-4185. PubMed ID: 37432534
    [Abstract] [Full Text] [Related]

  • 36. Non-HLA Autoantibodies at 1 Year Negatively Affect 5-Year Native Renal Function in Liver Transplant Recipients.
    O'Leary JG, Philippe A, Freeman R, Heidecke H, Jennings LW, Catar R, Klintmalm GB, Dragun D.
    Transplant Proc; 2021 Apr 15; 53(3):1019-1024. PubMed ID: 33579550
    [Abstract] [Full Text] [Related]

  • 37. Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies?
    Irure J, López-Hoyos M, Rodrigo E, Gómez-Román J, Ruiz JC, Arias M, San Segundo D.
    Transplant Proc; 2016 Nov 15; 48(9):2888-2890. PubMed ID: 27932099
    [Abstract] [Full Text] [Related]

  • 38. Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested?
    Philogene MC, Zhou S, Lonze BE, Bagnasco S, Alasfar S, Montgomery RA, Kraus E, Jackson AM, Leffell MS, Zachary AA.
    Hum Immunol; 2018 Apr 15; 79(4):195-202. PubMed ID: 29428484
    [Abstract] [Full Text] [Related]

  • 39. Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.
    Taniguchi M, Rebellato LM, Cai J, Hopfield J, Briley KP, Haisch CE, Catrou PG, Bolin P, Parker K, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI.
    Am J Transplant; 2013 Oct 15; 13(10):2577-89. PubMed ID: 23941128
    [Abstract] [Full Text] [Related]

  • 40. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.
    Giral M, Foucher Y, Dufay A, Duong Van Huyen JP, Renaudin K, Moreau A, Philippe A, Hegner B, Dechend R, Heidecke H, Brouard S, Cesbron A, Castagnet S, Devys A, Soulillou JP, Dragun D.
    Am J Transplant; 2013 Oct 15; 13(10):2567-76. PubMed ID: 23919486
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.